1/15中药、天然药物急性毒性研究技术指导原则二OO五年三月指导原则编号:【Z】GPT2-1目录一、概述················································································································································1二、基本原则········································································································································1（一）实验管理···································································································································1（二）具体问题具体分析·············································································································1（三）试验设计··································································································································2三、基本内容·······································································································································2（一）受试物·······································································································································2（二）实验动物··································································································································22/15（三）试验分组··································································································································2（四）给药途径·································································································2（五）给药容量·································································································································2（六）观察期限································································································································...
